Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Silk Road Medical Inc
2OWCurrent price
24.4 EUR
0 EUR (0.00%)
Last closed
27.49 USD
Company
silkroadmed.com
ISIN
US82710M1009
Sector
Healthcare
Industry
Medical Devices
Exchange
Frankfurt Exchange
Capitalization
1 116 976 384 USD
Yield for 12 month
+234.84 %
1Y
3Y
5Y
10Y
15Y
2OW
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation. Address: 1213 Innsbruck Drive, Sunnyvale, CA, United States, 94089
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
20.75 USDP/E ratio
–Dividend Yield
–Current Year
+177 134 000 USD
Last Year
+138 638 000 USD
Current Quarter
+51 242 000 USD
Last Quarter
+48 484 000 USD
Current Year
+127 086 000 USD
Last Year
+100 762 000 USD
Current Quarter
+38 506 000 USD
Last Quarter
+36 501 000 USD
Key Figures 2OW
1 year
3 years
5 years
10 years
EBITDA
-57 552 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-14.11 %
PEG Ratio
–
Return On Equity TTM
-36.45 %
Wall Street Target Price
20.75 USD
Revenue TTM
191 431 008 USD
Book Value
3.81 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
13.1 %
Dividend Yield
–
Gross Profit TTM
100 762 000 USD
Earnings per share
-1.45 USD
Diluted Eps TTM
-1.45 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-29.53 %
Dividend Analytics 2OW
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2OW
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2OW
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
5.3434
Price Sales TTM
5.8349
Enterprise Value EBITDA
-12.8365
Price Book MRQ
7.221
Financials 2OW
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2OW
For 52 weeks
7.61 USD
27.51 USD
50 Day MA
27.17 USD
Shares Short Prior Month
3 191 940
200 Day MA
21 USD
Short Ratio
2.48
Shares Short
3 147 223
Short Percent
7.87 %
BeatStart